Elting LS - Search Results

1

Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries.

Adams JR, Elting LS, Lyman GH, George JN, Lembersky BC, Armitage JO, Demetri GD, Bennett CL. Adams JR, et al. Among authors: elting ls. Am J Med. 2004 Jan 1;116(1):28-34. doi: 10.1016/j.amjmed.2003.06.004. Am J Med. 2004. PMID: 14706663

2

Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology.

Schiffer CA, Anderson KC, Bennett CL, Bernstein S, Elting LS, Goldsmith M, Goldstein M, Hume H, McCullough JJ, McIntyre RE, Powell BL, Rainey JM, Rowley SD, Rebulla P, Troner MB, Wagnon AH; American Society of Clinical Oncology. Schiffer CA, et al. Among authors: elting ls. J Clin Oncol. 2001 Mar 1;19(5):1519-38. doi: 10.1200/JCO.2001.19.5.1519. J Clin Oncol. 2001. PMID: 11230498

3

Mammography capacity impact on screening rates and breast cancer stage at diagnosis.

Elting LS, Cooksley CD, Bekele BN, Giordano SH, Shih YC, Lovell KK, Avritscher EB, Theriault R. Elting LS, et al. Am J Prev Med. 2009 Aug;37(2):102-8. doi: 10.1016/j.amepre.2009.03.017. Epub 2009 Jun 12. Am J Prev Med. 2009. PMID: 19524392

4

Outcomes and cost of deep venous thrombosis among patients with cancer.

Elting LS, Escalante CP, Cooksley C, Avritscher EB, Kurtin D, Hamblin L, Khosla SG, Rivera E. Elting LS, et al. Arch Intern Med. 2004 Aug 9-23;164(15):1653-61. doi: 10.1001/archinte.164.15.1653. Arch Intern Med. 2004. PMID: 15302635

5

Aztreonam therapy in neutropenic patients with cancer.

Jones PG, Rolston KV, Fainstein V, Elting L, Walters RS, Bodey GP. Jones PG, et al. Am J Med. 1986 Aug;81(2):243-8. doi: 10.1016/0002-9343(86)90258-5. Am J Med. 1986. PMID: 3526885 Clinical Trial.

6

Racial and ethnic differences in health behaviors among cancer survivors.

Nayak P, Paxton RJ, Holmes H, Thanh Nguyen H, Elting LS. Nayak P, et al. Among authors: elting ls. Am J Prev Med. 2015 Jun;48(6):729-36. doi: 10.1016/j.amepre.2014.12.015. Am J Prev Med. 2015. PMID: 25998923

7

Factors associated with immunotherapy use among newly diagnosed cancer patients.

Shih YC, Elting LS, Halpern MT. Shih YC, et al. Among authors: elting ls. Med Care. 2009 Sep;47(9):948-58. doi: 10.1097/MLR.0b013e31819a5b2b. Med Care. 2009. PMID: 19704352

8

Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia.

Elting LS, Rubenstein EB, Martin CG, Kurtin D, Rodriguez S, Laiho E, Kanesan K, Cantor SB, Benjamin RS. Elting LS, et al. J Clin Oncol. 2001 Feb 15;19(4):1137-46. doi: 10.1200/JCO.2001.19.4.1137. J Clin Oncol. 2001. PMID: 11181679

9

Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis.

Avritscher EB, Cooksley CD, Elting LS. Avritscher EB, et al. Among authors: elting ls. Semin Oncol Nurs. 2004 Feb;20(1):3-10. doi: 10.1053/j.soncn.2003.10.002. Semin Oncol Nurs. 2004. PMID: 15038511 Review.

10

Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies.

Elting LS, Cooksley CD, Chambers MS, Garden AS. Elting LS, et al. Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1110-20. doi: 10.1016/j.ijrobp.2007.01.053. Epub 2007 Mar 29. Int J Radiat Oncol Biol Phys. 2007. PMID: 17398022

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page